Medical device regulation in vascular ageing assessment: a VascAgeNet survey exploring knowledge and perception

References

• Zenios S, Makower J, Yock P, et al. Biodesign: the process of innovating medical technologies. Cambridge, England: Cambridge University Press; 2009.
   Google Scholar
• Mayer CC, Francesconi M, Grandi C, et al. Regulatory requirements for medical devices and vascular ageing: an overview. Heart Lung Circ [Internet]. 2021;30:1658–1666. doi: 10.1016/j.hlc.2021.06.517
   PubMed Web of Science ®Google Scholar
• Triantafyllou A, Elia S-A, Park C, et al. Developing a questionnaire on knowledge, perceptions and application of vascular-aging measurements. J Cardiovasc Dev Dis. 2023;10(2):10. doi: 10.3390/jcdd10020080
   Web of Science ®Google Scholar
• Panayiotou AG, Park C, Climie RE, et al. Limitations to implementation of measuring vascular ageing in routine clinical practice. J Hypertens. 2023;41(6):1054–1056. doi: 10.1097/HJH.0000000000003393
   PubMed Web of Science ®Google Scholar
• Carl A-K, Hochmann D. Impact of the new European medical device regulation: a two-year comparison. Biomed Technol (Berl). 2023. doi: 10.1515/bmt-2023-0325
   PubMed Web of Science ®Google Scholar
• Bretthauer M, Gerke S, Hassan C, et al. The new European medical device regulation: balancing innovation and patient safety. Ann Intern Med. 2023;176(6):844–848. doi: 10.7326/M23-0454
   PubMed Web of Science ®Google Scholar
• Holmes DRJ, Farb A, Dib N, et al. The medical device development ecosystem: Current regulatory state and challenges for future development a review. Cardiovasc Revasc Med. 2023;60:95–101. doi: 10.1016/j.carrev.2023.09.005
   PubMed Web of Science ®Google Scholar
• Garzotto F, Comoretto RI, Dorigo L, et al. Preparing healthcare, academic institutions, and notified bodies for their involvement in the innovation of medical devices under the new European regulation. Expert Rev Med Devices. 2022;19(8):613–621. doi: 10.1080/17434440.2022.2118046
   PubMed Web of Science ®Google Scholar
• Aronson JK, Heneghan C, Ferner RE. Medical devices: definition, classification, and regulatory implications. Drug Saf. 2020;43(2):83–93. doi: 10.1007/s40264-019-00878-3
   PubMed Web of Science ®Google Scholar
• Landeen KC, Langerman A, Maldonado F. An oversight in oversight: reconciling the medical device industry, clinicians, and regulation. Chest. 2022;161(1):300–302. doi: 10.1016/j.chest.2021.06.038
   PubMed Web of Science ®Google Scholar
• Fraser AG, Byrne RA, Kautzner J, et al. Implementing the new European regulations on medical devices-clinical responsibilities for evidence-based practice: a report from the regulatory affairs committee of the European society of cardiology. Eur Heart J. 2020;41:2589–2596. doi: 10.1093/eurheartj/ehaa382
   PubMed Web of Science ®Google Scholar
• Bianchini E, Mayer CC. Medical device regulation: should we care about it? Artery Res [Internet]. 2022. doi: 10.1007/s44200-022-00014-0
   PubMed Web of Science ®Google Scholar
• Melvin T, Torre M. New medical device regulations: the regulator’s view. EFORT Open Rev. 2019;4(6):351–356. doi: 10.1302/2058-5241.4.180061
   PubMed Web of Science ®Google Scholar
• Fraser AG, Nelissen RGHH, Kjærsgaard-Andersen P, et al. Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE–MD (coordinating research and evidence for medical devices). EFORT Open Rev. 2021;6(10):839–849. doi: 10.1302/2058-5241.6.210081
   PubMed Web of Science ®Google Scholar
• Huusko J, Kinnunen U-M, Saranto K. Medical device regulation (MDR) in health technology enterprises – perspectives of managers and regulatory professionals. BMC Health Serv Res. 2023;23(1):310. doi: 10.1186/s12913-023-09316-8
   PubMed Web of Science ®Google Scholar
• Claudia W, Sabine E. Perceived training needs of regulators, notified bodies and clinicians for successful implementation of the EU MDR: survey results. J Med Device Regul. 2023;20(2): 45–56. Available from: https://globalregulatorypress.com/product/perceived-training-needs-of-regulators-notified-bodies-and-clinicians-for-successful-implementation-of-the-eu-mdr-survey-results/
   Google Scholar
• Mayer CC, Climie RE, Hametner B, et al. The European COST action VascAgeNet fostering innovation — when industry comes to science. Artery Res. 2020;26(3):125–129. doi: 10.2991/artres.k.200430.001
   Web of Science ®Google Scholar
• Climie RE, Mayer CC, Bruno RM, et al. Addressing the unmet needs of measuring vascular ageing in clinical practice-european cooperation in science and technology action vascagenet. Artery Res. 2020;26:71–75. doi: 10.2991/artres.k.200328.001
   Web of Science ®Google Scholar
• Climie RE, Alastruey J, Mayer CC, et al. Vascular ageing – moving from bench towards bedside. Eur J Prev Cardiol. 2023;30(11):1101–1117. doi: 10.1093/eurjpc/zwad028
   PubMed Web of Science ®Google Scholar
• Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–188. doi: 10.1093/eurheartj/ehz455
   PubMed Web of Science ®Google Scholar
• Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–3337. doi: 10.1093/eurheartj/ehab484
   PubMed Web of Science ®Google Scholar
• Mancia G, Kreutz R, Brunström M, et al. 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European society of hypertension: endorsed by the International society of hypertension (ISH) and the European renal association. J Hypertens. 2023;41(12):1874–2071. doi: 10.1097/HJH.0000000000003480
   PubMed Web of Science ®Google Scholar
• Melvin T. The European medical device regulation–what biomedical engineers need to know. IEEE J Transl Eng Heal Med. 2022;10:1–5. doi: 10.1109/JTEHM.2022.3194415
   Google Scholar
• Dhainaut J-F, Blin O, Herry F, et al. Health research and innovation: can we optimize the interface between startups/pharmaceutical companies and academic health care institutions or not? Therapie. 2020;75(1):113–123. doi: 10.1016/j.therap.2019.11.010
   PubMed Web of Science ®Google Scholar
• Martina MR, Bianchini E, Sinceri S, et al. Software medical device maintenance: DevOps based approach for problem and modification management. J Softw Evol Proc. 2023;e2570. doi: 10.1002/smr.2570
   Web of Science ®Google Scholar
• Forsberg Lie M, Sanchez-Gordon M, Colomo-Palacios R. DevOps in an ISO 13485 regulated environment: A multivocal literature review. Int Symp Empir Softw Eng Meas [Internet]. IEEE Computer Society. 2020. [cited 2021 Feb 26]. Available from: http://arxiv.org/abs/2007.11295
   Google Scholar
• Bianchini E, Francesconi M, Testa M, et al. Unique device identification and traceability for medical software: a major challenge for manufacturers in an ever-evolving marketplace. J Biomed Inform. 2019;93:103150. doi: 10.1016/j.jbi.2019.103150
   PubMed Web of Science ®Google Scholar
• Ren Y, Bertoldi M, Fraser AG, et al. Validation of CORE-MD PMS support tool: a novel strategy for aggregating information from notices of failures to support medical devices’ post-market surveillance. Ther Innov Regul Sci. 2023;57(3):589–602. doi: 10.1007/s43441-022-00493-y
   PubMed Web of Science ®Google Scholar
• Vlachos I, Kalivas D, Panou-Diamandi O. An electronic post market surveillance system for medical devices. Comput Methods Programs Biomed [Internet]. 2003;71(2):129–140. doi: 10.1016/S0169-2607(02)00060-3
   PubMed Web of Science ®Google Scholar
• Fraser AG, Biasin E, Bijnens B, et al. Artificial intelligence in medical device software and high-risk medical devices – a review of definitions, expert recommendations and regulatory initiatives. Expert Rev Med Devices. 2023;20(6):467–491. doi: 10.1080/17434440.2023.2184685
   PubMed Web of Science ®Google Scholar
• Censi F, Mattei E, Triventi M, et al. Regulatory frameworks for mobile medical applications. Expert Rev Med Devices. 2015;12(3):273–278. doi: 10.1586/17434440.2015.1007125
   PubMed Web of Science ®Google Scholar
• Spronck B, Terentes-Printzios D, Avolio AP, et al. 2024 recommendations for validation of noninvasive arterial pulse wave velocity measurement devices. Hypertens (Dallas, Tex 1979). 2024;81(1):183–192. doi: 10.1161/HYPERTENSIONAHA.123.21618
   PubMed Web of Science ®Google Scholar
• Fong TS, Urbina EM, Howden EJ, et al. Youth vascular consortium (YVC) protocol: establishing reference intervals for vascular ageing in children, adolescents and young adults. Heart Lung Circ. 2021;30(11):1710–1715. doi: 10.1016/j.hlc.2021.05.107
   PubMed Web of Science ®Google Scholar
• Regulation (EU) 2017/746 of the European parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing directive 98/79/EC and commission decision 2010/227/EU (text with EEA relevance). 2023;11:1–205. https://eur-lex.europa.eu/eli/reg/2017/746/oj
   Google Scholar
• Ridker PM, Bhatt DL, Pradhan AD, et al. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. Lancet (London, England) [Internet] 2023;401:1293–1301. [cited 2023 Dec 21]. doi: 10.1016/S0140-6736(23)00215-5
   PubMed Web of Science ®Google Scholar